If you recently tested positive for COVID-19, the COVID Treatment Center at the UMass Memorial Medical Center’s Hahnemann campus in Worcester offers treatments that can prevent your symptoms from getting worse and keep you out of the hospital. These treatments are offered through a partnership with the Commonwealth of Massachusetts Department of Public Health (DPH).
We are providing the following treatments:
- Monoclonal antibodies (one-time infusion)
- Intravenous Remdesivir (3-day course)
- Oral Paxlovid (Nirmaltrevir and Ritonavir co-packaged)
- Oral Molnupiravir
Patients who are interested in receiving treatments for COVID-19 should have their primary care provider contact our Physician Referral Service at 800-431-5151 and request a referral to our COVID Treatment Center. We also recommend that patients discuss treatment options with their primary care provider.
If you do not have a primary care provider or prefer to self-refer, please visit COVID-19 Treatment Self-Referral. Providers in our center will assess patients to determine if they qualify for the treatments that we can provide in our clinic.
Currently, the DPH is managing the distribution of COVID medications that are coming from the Federal Government. Restrictions are assigned to each of the approved medications by the Food and Drug Administration and the significant increase in patients requires us to prioritize patients who are at high risk for complications in managing a positive COVID diagnosis.
New Treatment Offered
The COVID Treatment Center is now offering EVUSHELD™ (tixagevimab co-packaged with cilgavimab), a new medication that reduces the likelihood of contracting COVID-19 in patients who are not currently infected with coronavirus. EVUSHELD™ is not a substitute for vaccination – patients must be vaccinated in order to receive EVUSHELD™.
If you are interested in being evaluated for EVUSHELD™ treatment, please contact your primary care physician. If instead you wish to be evaluated by COVID Treatment Center staff for EVUSHELD™, please complete this form.